跳至主要内容
临床试验/NL-OMON22251
NL-OMON22251尚未招募不适用

Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: A multicentre randomized phase III clinical trial/

Academic Medical CenterDepartment of radiation oncologyMeibergdreef 91105 AZ AmsterdamThe NetherlandsPhone: +31 20 5665591E-mail: g.vantienhoven@amc.uva.nl0 个研究点目标入组 244 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
244

研究概览

简要总结

Van Tienhoven G, Gouma, DJ, Richel DJ. Neoadjuvant chemoradiotherapy has a potential role in pancreatic carcinoma Therapeutic Advances in Medical Oncology, 2011;3:27-33

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Histologically or cytologically confirmed adenocarcinoma of the pancreas;
  • 2. Primarily resectable tumours or Borderline resectable tumours (see table 1, p7 and hereunder) (exception, T1 centrally located tumours with no vascular involvement at all);

排除标准

  • 1. T1 resectable tumours, centrally located with no connection to the SMA, Celiac axis, CHA or SMV/PV;
  • 2. Clearly locally advanced, irresectable, tumours (see table 1, p7 and hereabove);

研究者

发起方
Academic Medical CenterDepartment of radiation oncologyMeibergdreef 91105 AZ AmsterdamThe NetherlandsPhone: +31 20 5665591E-mail: g.vantienhoven@amc.uva.nl

相似试验